BACKGROUND
Hypertension and hyperlipidemia are highly prevalent cardiometabolic disorders and major contributors to cardiovascular morbidity and mortality. These conditions frequently coexist and synergistically increase cardiovascular risk through mechanisms including endothelial dysfunction, vascular inflammation, an...
Saifullah Khan, Muhammad Vazaym, Muhammad Jawad et al.· Journal of the National Medi...· 0 citations
Coronary artery disease (CAD) is one of the major causes of death in the United States, whereas substance related conditions (SRC) are increasingly on the rise in the country. There is a paucity of information on national trends of CAD mortality over time with coexisting substance related conditions (SRC)....
M. Mustafa, Saifullah Khan, M. Saleem et al.· Journal of Epidemiology and...· 0 citations
Overall, zilebesiran produced significant and consistent BP reductions, especially in ambulatory measures, with a favorable safety profile, and builds on previous meta-analyses that included only 2 RCTs; this updated analysis reflects the need for novel therapeutic options.
Muhammad Hussain, Muhammad Hassan, Asharib Sohaib et al.· European Journal of Clinical...· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.